Dr. Gretel Terrero, MD

  • Miami, FL
  • Hematologist and oncologist
NPI1134509920PAC ID0446568190
Medicare services, 2024
238
Medicare patients, 2024
68
Part D claims, 2024
335
Publications
5
Clinical trials
1
Practice address
1475 Nw 12th Ave, Miami, FL 33136
Professional email
Get professional email
Personal email
Get personal email
Mobile number
Get mobile number
Social profiles

Primary practice

Sylvester Comprehensive Cancer Center

Hospital · Miami, Florida

Find Dr. Terrero's professional email, personal email and mobile number

Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.

View contacts for free

Dr. Gretel Terrero is a hematologist and oncologist in Miami, Florida

Dr. Terrero practices at Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

Dr. Terrero's NPI, 1134509920, was assigned on June 5, 2015. Dr. Terrero graduated from The Warren Alpert Medical School of Brown University in 2015. Dr. Terrero holds Florida license ME149408.

NPI and contact details
Medicare PAC ID
0446568190
NPI enumeration date
June 5, 2015
NPI status
Active
Accepts Medicare assignment
Yes
Offers telehealth
Yes
Professional email
Get email
Personal email
Get email
Mobile number
Get number
Sex
Female
Estimated age
37
Medical school graduation
2015

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)

Dr. Gretel Terrero practices at Sylvester Comprehensive Cancer Center in Miami, Florida

Dr. Terrero's primary practice is Sylvester Comprehensive Cancer Center, at 1475 Nw 12th Ave, Miami, FL 33136.

Source: Dmand AI Affiliation Data

Dr. Gretel Terrero is affiliated with 2 sites of care and 1 medical group

Dr. Terrero's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami. Dr. Terrero is also affiliated with Jackson Memorial Hospital. The medical group on file is University of Miami Health System.

Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data

Dmand AI tracks the EHR system at Dr. Gretel Terrero's practice

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Terrero practices, 2 sites in all. Vendor and product names are available with a free account.

EHR by site
SiteEHR vendor and product
Sylvester Comprehensive Cancer CenterAvailable with a free account
+1 more affiliated siteAvailable with a free account

Source: Dmand AI Technology Install Data

For health IT teams

See the EHR and IT leaders at every hospital where Dr. Terrero practices

Dmand AI maps EHR vendors, IT decision makers and buying committees across University of Miami and 6.2K+ hospitals, with verified contacts in the same login.

Dr. Gretel Terrero is one of 693 hematologists and oncologists in Florida

Hematology and oncology is Dr. Terrero's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dr. Terrero is board certified in hematology by the American Board of Internal Medicine. Dmand AI has Dr. Terrero's licenses on file in 2 states: Florida and Massachusetts.

Specialties and state licenses

  • Hematology and oncology, FloridaPrimaryLicense ME149408 · 2021 to 2027 · taxonomy 207RH0003X
  • Massachusetts license2015 to 2018

Clinical focus

Dmand AI lists colorectal cancer among the conditions Dr. Terrero treats.

Hematologists and oncologists near Dr. Terrero

Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.

Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks

Dr. Gretel Terrero billed Medicare for 238 services in 2024

CMS data shows 238 Medicare services from Dr. Terrero across 4 procedure codes in 2024, for 68 Medicare patients. Medicare paid $18,383 for them.

Medicare services, 2024238
Medicare patients68
Paid by Medicare$18,383
Procedure codes4

Dr. Terrero's Medicare services by type, 2024

  1. Office and hospital visits149
  2. Other services89

Where Dr. Terrero's Medicare services took place, 2024

  • In an office12653%
  • In a facility11247%

Dr. Terrero compared with the Florida median for hematologists and oncologists, 2024

  • Dr. Terrero
  • Florida median
Medicare services
238vs 69766% below
Medicare patients
68vs 21869% below
Part D claims
194vs 34143% below

Medians across 638 hematologists and oncologists in Florida with Dmand AI profiles that report each measure.

Dr. Terrero's most billed Medicare procedure codes, 2024

CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.

See all procedures by Dr. Terrero

Need commercial claims for Dr. Terrero?

Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Terrero and other hematologists and oncologists in Florida.

Book a meeting

Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks

Dr. Gretel Terrero treated 68 Medicare patients in 2024, average age 70

CMS counts 68 Medicare patients who saw Dr. Terrero in 2024. The largest group is 65 to 74, with 35 patients. 75% of them have high blood pressure, and 68% have high cholesterol. 53% are also on Medicaid. Their average risk score is 2.30, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Terrero's median patient age at 69, with 57% women.

Medicare patients, 202468
Average age70
Average risk score2.30
Also on Medicaid53%

Dr. Terrero's Medicare patients by age, 2024

CMS leaves out age groups with fewer than 11 patients.

Dr. Terrero's Medicare patients by sex, 2024

  • Women3247%
  • Men3653%

Chronic conditions among Dr. Terrero's Medicare patients, 2024

  1. High blood pressure75%
  2. High cholesterol68%
  3. Cancer63%
  4. Arthritis44%
  5. Mood disorders43%
  6. Anxiety40%
  7. Depression37%
  8. Diabetes37%

Share of Medicare patients with each condition. A patient can have several.

Dr. Terrero's patients across all payers

Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.

Patient panel by age, all payers

Median age 69

Patient panel by sex, all payers

  • Women57%
  • Men41%

Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data

Dr. Gretel Terrero wrote 335 Medicare Part D claims in 2024

In 2024, Dr. Terrero wrote 335 Medicare Part D claims for 37 patients. 79% of them were for generic drugs. CMS names the drug for 194 of them, across 11 drugs with 11 or more claims each, at $71,928 in total drug cost. In 2023, CMS named 15 claims across 1 drug.

Part D claims, 2024335
Drugs named by CMS11
Total drug cost$71,928
Part D patients37

Dr. Terrero's Part D claims by kind of drug, 2024

  • Generic263 claims79%
  • Brand-name72 claims21%

Dr. Terrero's most prescribed drugs by claims, 2024

CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.

Drug classes CMS tracks in Dr. Terrero's Part D claims, 2024

  • Opioids4%13 of 335 claims

Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.

Part D claims for drugs CMS names, 2023 to 2024

  • 2023
  • 2024
Claims for drugs CMS names
2023: 152024: 1941193%

Drugs named by CMS: 11 in 2024, 1 in 2023.

See all prescribing by Dr. Terrero

Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data

Dr. Gretel Terrero scored 88 out of 100 in Medicare's MIPS program for 2024

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 88 out of 100 for Dr. Terrero for performance year 2024, reported as part of a group. Dr. Terrero accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Terrero as offering telehealth.

Accepts Medicare assignment
Yes
Offers telehealth
Yes

Dr. Terrero's MIPS scores, performance year 2024

  • 88of 100Final score
  • 78.8of 100Quality
  • 100of 100Promoting Interoperability
  • 40of 100Improvement Activities
  • 71of 100Cost

Each score is out of 100. The final score weighs the categories CMS scored for this clinician.

Sources: Doctors and Clinicians National Downloadable File (CMS); and Clinician Public Reporting: Overall MIPS Performance (CMS), 2024 data, released September 10, 2026

For MedTech and pharma teams

Find hematologists and oncologists like Dr. Terrero by procedure volume and prescribing

Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.

Dr. Gretel Terrero has 5 publications on record

Dmand AI links 5 papers to Dr. Terrero, published from 2014 to 2021. The most frequent topics are Antineoplastic Combined Chemotherapy Protocols. Dr. Terrero's most frequent co-authors are Albert C. Lockhart, MD, Manik A. Amin, MD and Maria Quintos Baggstrom, MD.

Papers5
Years published2014 to 2021

Dr. Terrero's papers by year, 2014 to 2021

Topics Dr. Terrero writes about most

  • Antineoplastic Combined Chemotherapy Protocols

Dr. Terrero's most frequent co-authors

Recent publications by Dr. Terrero

See all 5 publications and co-authors

See who Dr. Terrero researches with

Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Terrero works with, so you can find a warm path to the right hematologists and oncologists.

How network discovery works

Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage

Dr. Gretel Terrero has worked on 1 clinical trial

Dmand AI links Dr. Terrero to 1 clinical trial. 1 is still active or recruiting. Conditions studied include Gallbladder Neoplasms and Gallbladder Diseases.

Conditions in Dr. Terrero's trials

  • Gallbladder Neoplasms
  • Gallbladder Diseases

Recent clinical trials with Dr. Terrero

Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)

Dr. Gretel Terrero received $5,387 in industry payments from 2018 to 2025

CMS Open Payments shows 29 general payments to Dr. Terrero from 12 drug and device companies from 2018 to 2025. Consulting fees make up the largest share, 78% of the total. AstraZeneca Pharmaceuticals LP paid the most, $4,223.

General payments to Dr. Terrero by program year, 2018 to 2025

General payments to Dr. Terrero by kind, 2018 to 2025

$5.4Kin total
  • Consulting fees$4,18878%
  • Food and beverage$90017%
  • Education$3006%

Companies that paid Dr. Terrero the most, 2018 to 2025

Share is of all general payments to this clinician.

See all payments to Dr. Terrero

Source: Open Payments (CMS), 2025 data, released July 7, 2026

Dr. Gretel Terrero has 2 awards and honors on record

Dmand AI lists 2 awards for Dr. Terrero, most recently K12 Award in 2024.

Awards and honors for Dr. Terrero

  1. 2024
    • K12 Award
  2. 2018
    • Nuestras Estrellas Award

Source: Dmand AI Professional Profile Data

Dr. Gretel Terrero graduated from The Warren Alpert Medical School of Brown University

Dr. Terrero graduated from The Warren Alpert Medical School of Brown University in 2015. Dr. Terrero is a member of AMA and ASCO.

  1. Medical schoolThe Warren Alpert Medical School of Brown University
  2. Board certified in hematologyAmerican Board of Internal Medicine
  3. Board certified in internal medicineAmerican Board of Internal Medicine
  4. Board certified in medical oncologyAmerican Board of Internal Medicine

Source: Dmand AI Professional Profile Data

Dr. Gretel Terrero accepts plans from 11 insurance carriers

Dr. Terrero is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.

  • Aetna
  • United Healthcare
  • Blue Cross Blue Shield of Michigan
  • Cigna
  • Elevance
  • Aspirus Health Plan
  • Blue Cross and Blue Shield of Kansas City
  • CMS Medicare
  • +3 more carriersWith a free account

Plan types Dr. Terrero accepts, by number of carriers

  1. PPO7
  2. HMO5
  3. Medicare4
  4. POS4
  5. EPO2
  6. Medicaid1

Source: Dmand AI Insurance Network Data

Sources for Dr. Gretel Terrero's profile data

Sources for the data on this page
Data on this pageSource
NPI, name, sex, specialty and licensesNPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data
Practice locations and phoneDmand AI Affiliation Data
Primary practice, affiliations and health systemDmand AI Affiliation DataDmand AI Org Hierarchy Data
Medicare services and procedure codesMedicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab)
State medians for the same specialtyDmand AI Peer Benchmarks
Medicare patients and the all-payer patient panelDmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab)
Part D prescribingMedicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab)
MIPS scores, telehealth, assignment and procedure percentilesDoctors and Clinicians National Downloadable File (CMS) (opens in a new tab)Clinician Public Reporting: Overall MIPS Performance (CMS) (opens in a new tab)
Publications, topics and co-authorsPubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage
Clinical trials and co-investigatorsDmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab)
Industry paymentsOpen Payments (CMS) (opens in a new tab)
Awards and committee rolesDmand AI Professional Profile Data
Training, board certification and membershipsDmand AI Professional Profile Data
Insurance carriers and plan typesDmand AI Insurance Network Data
EHR at each practice siteDmand AI Technology Install Data
Similar physiciansDmand AI Affiliation Data

Data last refreshed October 2026Report an inaccuracyRemove my information

FAQ

Frequently asked questions about Dr. Gretel Terrero

Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.

What is Dr. Gretel Terrero's NPI number?

Dr. Gretel Terrero's NPI number is 1134509920. It was assigned on June 5, 2015, and it is active in the NPI Registry.

What kind of doctor is Dr. Gretel Terrero?

Dr. Gretel Terrero is a hematologist and oncologist in Miami, Florida. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).

Where does Dr. Gretel Terrero practice?

Dr. Terrero practices at 1475 Nw 12th Ave, Miami, FL 33136. Dr. Terrero's primary practice is Sylvester Comprehensive Cancer Center in Miami, Florida, part of University of Miami.

What is Dr. Gretel Terrero's medical license number?

Dr. Terrero holds Florida license ME149408, one of the licenses on file in 2 states.

Which states has Dr. Gretel Terrero been licensed in?

Dmand AI has state licenses on file for Dr. Terrero in Florida (2021 to 2027) and Massachusetts (2015 to 2018).

Which hospitals is Dr. Gretel Terrero affiliated with?

Dr. Terrero practices at Sylvester Comprehensive Cancer Center in Miami, Florida. Dr. Terrero is also affiliated with Jackson Memorial Hospital.

What medical group is Dr. Gretel Terrero part of?

Dr. Terrero is linked to University of Miami Health System.

Does Dr. Gretel Terrero accept Medicare?

Yes. CMS data shows Dr. Terrero billed Medicare for 238 services in 2024, and Dr. Terrero accepts Medicare assignment.

Does Dr. Gretel Terrero offer telehealth?

Yes. The CMS Doctors and Clinicians file lists Dr. Terrero as offering telehealth services.

What is Dr. Gretel Terrero's MIPS score?

Dr. Terrero's MIPS final score for performance year 2024 is 88 out of 100, reported as part of a group.

Show 10 more questionsShow fewer questions

How many Medicare patients does Dr. Gretel Terrero see?

CMS counts 68 Medicare patients who saw Dr. Terrero in 2024, with an average age of 70.

Is Dr. Gretel Terrero board certified?

Yes. Dr. Terrero is board certified in hematology by the American Board of Internal Medicine.

What services does Dr. Gretel Terrero bill to Medicare?

In 2024, Dr. Terrero's most billed Medicare services were office visit, established patient (99215), medicare service (G2211) and hospital inpatient care (99223).

Where did Dr. Gretel Terrero go to medical school?

Dr. Terrero graduated from The Warren Alpert Medical School of Brown University in 2015.

What drugs does Dr. Gretel Terrero prescribe most?

In 2024 Medicare Part D data, Dr. Terrero's most prescribed drugs by claims were Ondansetron ODT, Prednisone and Creon.

Has Dr. Gretel Terrero received payments from drug or device companies?

CMS Open Payments shows $5,387 in general payments to Dr. Terrero from 12 companies from 2018 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.

How long has Dr. Gretel Terrero been practicing?

Dr. Terrero graduated from medical school in 2015, 11 years ago.

Does Dr. Gretel Terrero do research?

Dmand AI links 5 publications to Dr. Terrero, published from 2014 to 2021. Dr. Terrero has worked on 1 clinical trial.

Who does Dr. Gretel Terrero publish with?

Dr. Terrero's most frequent co-authors are Albert C. Lockhart, MD (2 shared papers), Manik A. Amin, MD (1 shared paper) and Maria Quintos Baggstrom, MD (1 shared paper).

What insurance does Dr. Gretel Terrero accept?

Dr. Terrero is in network with 11 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 7. Check the plan with the practice before a visit.

Selling to hematology and oncology practices?

See hematologists and oncologists in Florida by site of care and group

Find the practices, groups and hospitals they work with, and the right people to contact at each.

  • 30 days free
  • Self-serve
  • No credit card

Cookie settings

Turn each category on or off. Your choice is kept for 12 months and you can change it here at any time.

Necessary

Always on. Sign-in, security, downloads you asked for, your cookie choice, and the page that led to a signup.

View cookies (6)
  • dm_consentDmand AI. Your cookie choices and whether your browser sent a Global Privacy Control signal. 12 months.
  • dm_ft, dm_ltDmand AI. The first and the latest page you arrived on, with the date, so a signup is credited to the page that worked. 90 days, 30 days.
  • dm_fs, dm_lsDmand AI. The first and the latest source of a visit (a search engine, a campaign or the site that linked here). 90 days, 30 days.
  • dm_dl, dm_dl_okDmand AI. After you give an email address for a download, lets you download files without being asked again. 30 days.
  • Session and CSRF cookiesDmand AI (app.dmand.ai). Sign-in and form protection in the application. Session.
  • __cf_bm, cf_clearanceCloudflare. Tells people from automated traffic and keeps the site available. 30 minutes; cf_clearance while a security check is valid.

Analytics

On unless you turn it off. How pages are used, in aggregate, and recordings of how pages are used.

View cookies (6)
  • Google Tag ManagerGoogle. Loads the analytics and marketing tags that are on. Sets no cookie of its own and does not load when both categories are off. n/a.
  • _ga, _ga_<container-id>Google Analytics 4. Visits and page views in aggregate on dmand.ai. 2 years.
  • _clck, _clskMicrosoft Clarity. Recordings and heatmaps of how pages are used, with form fields masked. 1 year, 1 day.
  • CLID, MUID, ANONCHK, MR, SMMicrosoft (clarity.ms). Set by Microsoft when Clarity loads, to recognize a browser across sites that use Clarity. Up to 1 year.
  • None (cookieless)Ahrefs Analytics. Page views in aggregate. n/a.
  • ph_<project>_posthogPostHog. Product usage, errors and performance in app.dmand.ai, used to fix bugs and improve features. 365 days.

Marketing

On unless you turn it off, and always off when your browser sends a Global Privacy Control signal. A visitor identification service tells our sales team which companies and people visit.

View cookies (6)
  • _reb2buid, _reb2butkRB2B. Recognizes a returning browser for visitor identification. 360 days, 1 year.
  • _reb2bgeoRB2B. The location used to decide whether a visit can be identified. 20 days.
  • _reb2brefRB2B. The page or site that referred the visit. 15 days.
  • _reb2bfxf, _reb2btd, _reb2bliRB2B. Links the visit to an identified business profile. 1 month.
  • _reb2bresolveRB2B. Holds a match while it is being resolved. 2 days.
  • _reb2sessionID, _reb2bloadedRB2B. The current visit, and a guard against loading the script twice. 30 minutes, 1 second.

Functional

On unless you turn it off. Remembers choices such as a collapsed section.

View cookies (none today)